Showing 5611-5620 of 20455 results for "".
- Exploring Exercise-Based Alternatives in Obstructive Sleep Apnea Managementhttps://reachmd.com/news/exploring-exercise-based-alternatives-in-obstructive-sleep-apnea-management/2476094/The search for alternatives to continuous positive airway pressure (CPAP) is expanding as patients with obstructive sleep apnea (OSA) increasingly seek non-traditional treatment strategies. Exercise-based therapies are gaining attention, particularly for their role in strengthening upper ai
- Understanding the Neurobehavioral Mechanisms of Fear and Anxiety in Multiple Sclerosishttps://reachmd.com/news/understanding-the-neurobehavioral-mechanisms-of-fear-and-anxiety-in-multiple-sclerosis/2476096/Fear and anxiety loom large in the lives of individuals with Multiple Sclerosis (MS). These emotional states are not merely reactions to the condition; they are entwined with the neurobehavioral mechanisms of the disease itself. This complex interplay challenges healthcare providers
- Navigating Thyroid Cancer: The Hashimoto’s Linkhttps://reachmd.com/news/navigating-thyroid-cancer-the-hashimotos-link/2476098/In recent propensity score–matched research (HR=0.65, 95% CI [0.45–0.85], p=0.003), clinicians observed that Hashimoto’s thyroiditis appears to modulate tumor behavior differently in younger women versus older men. Specifically, glandular inflammation in premenopausal patients was linked to
- AMI Pharm Advances AYP-101 to Phase 3 Testing for Noninflammatory Fat Reductionhttps://reachmd.com/news/ami-pharm-advances-ayp-101-to-phase-3-testing-for-noninflammatory-fat-reduction/2476093/AMI Pharm has initiated a pivotal Phase 3 clinical trial of AYP-101, an investigational injectable for the treatment of submental fat. The study will evaluate the efficacy and safety of the agent, which is designed to reduce localized fat with fewer inflammatory side effects than current therapie
- Revolutionizing Radiology: The Convergence of Advanced MRI and AI in Cancer Diagnosticshttps://reachmd.com/news/revolutionizing-radiology-the-convergence-of-advanced-mri-and-ai-in-cancer-diagnostics/2476082/As cancer diagnostics evolve, the integration of advanced MRI techniques and artificial intelligence is revolutionizing radiology, promising more accurate and non-invasive solutions. Radiologists now navigate a landscape where detecting clinically significant disease must be balanced
- Gut Microbiome Chemistry and Colorectal Cancer: A New Therapeutic Horizonhttps://reachmd.com/news/gut-microbiome-chemistry-and-colorectal-cancer-a-new-therapeutic-horizon/2476073/The gastrointestinal microbiome is reshaping our understanding of colorectal cancer progression while modulating non-antibiotic medications to influence patient outcomes. Research presented in
- 2025 AHA/ACC Guideline: Transforming Cardiovascular Carehttps://reachmd.com/news/2025-ahaacc-guideline-transforming-cardiovascular-care/2476074/According to the 2025 AHA/ACC guideline update on cardiovascular prevention, with cardiovascular diseases remaining a leading cause of morbidity and mortality worldwide, cutting-edge strategies are essential. From lifestyle interventions to novel surgical techniques, this article ex
- Staying Ahead: 2025 Primary Care and Obstetric Guideline Updateshttps://reachmd.com/news/staying-ahead-2025-primary-care-and-obstetric-guideline-updates/2476075/As primary care evolves, staying ahead with the latest guidelines is paramount for optimal patient care. The 2025 updates bring significant changes to managing both common outpatient conditions and obstetric care, promising improvements in integrated, patient-centered approaches.
- Transforming Wound Care: The Bluetooth-Enabled Smart Patchhttps://reachmd.com/news/transforming-wound-care-the-bluetooth-enabled-smart-patch/2476066/In the evolving world of healthcare, innovations that fuse technology with patient care continue to emerge, offering remarkable solutions. The Bluetooth-enabled smart wound patch, developed by RMIT University, exemplifies a significant stride in integrating technology with wound management.
- Allergan Aesthetics Announces New ‘Faces of Natrelle’ Campaignhttps://reachmd.com/news/allergan-aesthetics-announces-new-faces-of-natrelle-campaign/2476065/Allergan Aesthetics, an AbbVie company, has introduced “Faces of Natrelle,” a campaign centered on patient narratives surrounding breast augmentation and reconstruction using Natrelle silicone-filled breast implants. The initiative features 9 women selected through a national casting call,